Filter posts

Buy Side Investors Bullish Ahead of 2014 BIO CEO & Investor Conference

2013 was a record year for the biotech sector, with the NASDAQ Biotechnology Index hitting …

Prosensa's IPO and the Value of the BIO Investor Forum

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of …

Biotech Hall of Fame: Interview with Biotech’s First Investment Banker

Earlier this week, I had the opportunity to discuss biotech’s storied history with Fred Frank, …

BIO Investor Forum: The New Kids on the Biotech Block

Where should biotech start-ups look for funding in the venture capital desert that is becoming …

2012 BIO Investor Forum: Discovery Track Snapshot

BIO’s 11th Annual BIO Investor Forum is just around the corner – it will be …

2012 BIO Investor Forum: Looking Ahead to Investment Opportunities

The biggest biotech news out of Washington in recent months was the Jumpstart Our Business …

Picks and Pans – The Buy-Side View for 2012

What’s the forecast for biotech in 2012? Do investors think it is a good time …

BioFlorida Conference: Here's What You Missed

As I mentioned last week, BIO President & CEO James C. Greenwood kicked-off  this week’s …